New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2013
13:25 EDTCPHDCepheid weakness a buying opportunity, says Canaccord
Canaccord views today's pullback in shares of Cepheid as overdone and reiterates a Buy rating on the stock.
News For CPHD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
10:04 EDTCPHDCepheid issued a long-term Sell rating at Off Wall Street Research
Subscribe for More Information
June 26, 2015
10:00 EDTCPHDOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:05 EDTCPHDCepheid upgraded to Buy from Hold at Craig-Hallum
Craig-Hallum upgraded Cepheid to Buy and raised its price target to $75 from $52. The firm said Cepheid is rapidly expanding its clinical offering and customer reach and is emerging as the leading platform for molecular diagnostics.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use